Adipocytokines: mediators linking adipose tissue, inflammation and immunity

被引:2422
作者
Tilg, Herbert
Moschen, Alexander R.
机构
[1] Innsbruck Med Univ, Christian Doppler Res Lab Gut Inflammat, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Med, A-6020 Innsbruck, Austria
基金
奥地利科学基金会;
关键词
D O I
10.1038/nri1937
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There has been much effort recently to define the role of adipocytokines, which are soluble mediators derived mainly from adipocytes (fat cells), in the interaction between adipose tissue, inflammation and immunity. The adipocytokines adiponectin and leptin have emerged as the most abundant adipocyte products, thereby redefining adipose tissue as a key component not only of the endocrine system, but also of the immune system. Indeed, as we discuss here, several adipocytokines have a central role in the regulation of insulin resistance, as well as many aspects of inflammation and immunity. Other adipocytokines, such as visfatin, have only recently been identified. Understanding this rapidly growing family of mainly adipocyte-derived mediators might be of importance in the development of new therapies for obesity-associated diseases.
引用
收藏
页码:772 / 783
页数:12
相关论文
共 120 条
[1]   Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells [J].
Aleffi, S ;
Petrai, I ;
Bertolani, C ;
Parola, M ;
Colombatto, S ;
Novo, E ;
Vizzutti, F ;
Anania, FA ;
Milani, S ;
Rombouts, K ;
Laffi, G ;
Pinzani, M ;
Marra, F .
HEPATOLOGY, 2005, 42 (06) :1339-1348
[2]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[3]   IKK-β links inflammation to obesity-induced insulin resistance [J].
Arkan, MC ;
Hevener, AL ;
Greten, FR ;
Maeda, S ;
Li, ZW ;
Long, JM ;
Wynshaw-Boris, A ;
Poli, G ;
Olefsky, J ;
Karin, M .
NATURE MEDICINE, 2005, 11 (02) :191-198
[4]   Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance [J].
Axelsson, J ;
Bergsten, A ;
Qureshi, AR ;
Heimbürger, O ;
Bárány, P ;
Lönnqvist, FL ;
Lindholm, B ;
Nordfors, L ;
Alvestrand, A ;
Stenvinkel, P .
KIDNEY INTERNATIONAL, 2006, 69 (03) :596-604
[5]   Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Hardies, LJ ;
Pratipanawatr, T ;
DeFronzo, RA .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (06) :783-789
[6]  
Barbier M, 2003, GASTROEN CLIN BIOL, V27, P987
[7]   ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism [J].
Berg, AH ;
Combs, TP ;
Scherer, PE .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (02) :84-89
[8]   Crohn's disease clinical course and severity in obese patients [J].
Blain, A ;
Cattan, S ;
Beaugerie, L ;
Carbonnel, F ;
Gendre, JP ;
Cosnes, J .
CLINICAL NUTRITION, 2002, 21 (01) :51-57
[9]   Changes of adiponectin oligomer composition by moderate weight reduction [J].
Bobbert, T ;
Rochlitz, H ;
Wegewitz, U ;
Akpulat, S ;
Mai, K ;
Weickert, MO ;
Möhlig, M ;
Pfeiffer, AFH ;
Spranger, J .
DIABETES, 2005, 54 (09) :2712-2719
[10]   Resistin, an adipokine with potent proinflammatory properties [J].
Bokarewa, M ;
Nagaev, I ;
Dahlberg, L ;
Smith, U ;
Tarkowski, A .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5789-5795